StockWatch
·
HomeLiveWeekly

SOLIGENIX, INC.

Ticker: 812796

OverviewP/LShare Hold
values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-2.57-0.691.183.06Q1 FY2023Q2 FY2023Q3 FY2023Q3 FY2023Q1 FY2024Q1 FY2024Q2 FY2024Q2 FY2024

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q1 FY2023Q2 FY2023Q3 FY2023Q3 FY2023Q1 FY2024Q1 FY2024Q2 FY2024Q2 FY2024
PeriodQ2 FY2024Q2 FY2024Q1 FY2024Q1 FY2024Q3 FY2023Q3 FY2023Q2 FY2023Q1 FY2023
INCOME
Revenue0.000.00-100.0%0.12+0.0%0.12-7.7%0.13+0.0%0.13-38.1%0.21-19.2%0.26
Total Income0.000.00-100.0%0.12+0.0%0.12-7.7%0.13+0.0%0.13-38.1%0.21-19.2%0.26
EXPENSES
Expenditure1.75+0.0%1.75-21.5%2.23+0.0%2.23+16.8%1.91+0.0%1.91+3.8%1.84-23.7%2.41
Tax———————-1.16
PROFIT
PBT-1.64+0.0%-1.64+14.6%-1.92+0.0%-1.92-15.7%-1.66+0.0%-1.66-3.1%-1.61+27.1%-2.21
Net Profit-1.64+0.0%-1.64+14.6%-1.92+0.0%-1.92-15.7%-1.66+0.0%-1.66-3.1%-1.61-53.3%-1.05
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-1.31+0.0%-1.31-627.8%-0.18+93.8%-2.91-13.7%-2.56-1500.0%-0.16+27.3%-0.22+38.9%-0.36

Corporate Events

Board MeetingSNGX
2026
11Jun

Board Meeting

Cessation of Richard C. Straube, MD, as Consulting Chief Med…

SEC Filing ↗